Stage IIIB Cutaneous Melanoma AJCC v7 Recruiting Phase 2 / 3 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02339571A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced MelanomaTreatment